Share on StockTwits

Shire PLC (LON:SHP)‘s stock had its “buy” rating restated by Societe Generale in a research note issued on Tuesday, StockRatingsNetwork reports. They currently have a GBX 4,010 ($67.54) target price on the stock. Societe Generale’s price target suggests a potential upside of 22.08% from the company’s current price.

A number of other firms have also recently commented on SHP. Analysts at Citigroup Inc. raised their price target on shares of Shire PLC from GBX 4,000 ($67.37) to GBX 4,100 ($69.06) in a research note on Friday. They now have a “buy” rating on the stock. Separately, analysts at Deutsche Bank reiterated a “buy” rating on shares of Shire PLC in a research note on Friday. They now have a GBX 3,920 ($66.03) price target on the stock. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. Shire PLC presently has an average rating of “Buy” and an average price target of GBX 2,870.58 ($48.35).

Shares of Shire PLC (LON:SHP) traded up 0.91% on Tuesday, hitting GBX 3315.0002. 812,094 shares of the company’s stock traded hands. Shire PLC has a 1-year low of GBX 1978.0001 and a 1-year high of GBX 4133.00. The stock has a 50-day moving average of GBX 3099.66 and a 200-day moving average of GBX 2998.89. The company’s market cap is £19.370 billion.

Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.